A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell

Trial Profile

A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell

Completed
Phase of Trial: Phase 0

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Romidepsin (Primary)
  • Indications T cell lymphoma
  • Focus Therapeutic Use
  • Acronyms Ro-ENKTL
  • Most Recent Events

    • 09 Dec 2015 Results published in the Annals of Oncology
    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top